Real‐world effectiveness and safety of baricitinib in Japanese patients with atopic dermatitis: A single‐center retrospective study

Supporting Information Table S1 Patient demographics and baseline disease characteristics Supporting Information Table S2 Details of 14 patients with atopic dermatitis treated with baricitinib Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.